Clinical trials
Phase 3 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
642 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 318 |
| 2021 | 175 |
| 2022 | 77 |
| 2023 | 38 |
| 2024 | 14 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 301 |
| Unknown status | 157 |
| Terminated | 93 |
| Withdrawn | 58 |
| Recruiting | 15 |
| Active, not recruiting | 9 |
| Suspended | 7 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 16 |
| Assistance Publique - Hôpitaux de Paris | 13 |
| BioNTech SE | 11 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 8 |
| Novavax | 8 |
| Susanna Naggie, MD | 8 |
| Ain Shams University | 6 |
| AstraZeneca | 6 |
| Gilead Sciences | 6 |
| ModernaTX, Inc. | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 642 |
| Coronavirus Infections | 102 |
| Severe Acute Respiratory Syndrome | 52 |
| Pneumonia | 32 |
| Respiratory Distress Syndrome | 22 |
| Virus Diseases | 22 |
| Pneumonia, Viral | 16 |
| Coronaviridae Infections | 15 |
| RNA Virus Infections | 15 |
| Nidovirales Infections | 13 |
Trials
Showing 26 to 50 of 642. Each trial links to its page on Pharma Observatory.
542 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.